Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I

SC Campbell, PE Clark, SS Chang, JA Karam… - The Journal of …, 2021 - auajournals.org
Purpose: This AUA Guideline focuses on evaluation/counseling/management of adult
patients with clinically-localized renal masses suspicious for cancer, including solid …

Robot-assisted radical nephrectomy: a systematic review and meta-analysis of comparative studies

F Crocerossa, U Carbonara, F Cantiello, M Marchioni… - European urology, 2021 - Elsevier
Context Radical nephrectomy (RN) is the gold standard treatment for large and locally
advanced renal tumors. Although robot-assisted radical nephrectomy (RRN) is being …

Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal

S Turajlic, H Xu, K Litchfield, A Rowan, T Chambers… - Cell, 2018 - cell.com
Clear-cell renal cell carcinoma (ccRCC) exhibits a broad range of metastatic phenotypes
that have not been systematically studied to date. Here, we analyzed 575 primary and 335 …

Three risk of bias tools lead to opposite conclusions in observational research synthesis

JM Losilla, I Oliveras, JA Marin-Garcia… - Journal of clinical …, 2018 - Elsevier
Objectives The aim of this study was to assess the agreement and compare the performance
of three different instruments in assessing risk of bias (RoB) of comparative cohort studies …

French AFU Cancer Committee Guidelines-update 2022-2024: management of kidney cancer

P Bigot, P Barthelemy, R Boissier, ZE Khene… - Progrès en Urologie, 2022 - Elsevier
Aim To update the recommendations for the management of kidney cancers. Methods A
systematic review of the literature was conducted from 2015 to 2022. The most relevant …

Individualised indications for cytoreductive nephrectomy: which criteria define the optimal candidates?

A Larcher, CJD Wallis, A Bex, ML Blute… - European Urology …, 2019 - Elsevier
Context The current role of cytoreductive nephrectomy (CN) is controversial. Objective
Review of the available evidence about criteria defining CN optimal candidates. Evidence …

Recent advances in single-cell RNA-sequencing of primary and metastatic clear cell renal cell carcinoma

AM Alchahin, I Tsea, N Baryawno - Cancers, 2023 - mdpi.com
Simple Summary In recent years, several therapeutic advances have been made in clear
cell renal cell carcinoma (ccRCC) resulting in novel treatment regimens of increased …

Retrospective multicenter long-term follow-up analysis of prognostic risk factors for recurrence-free, metastasis-free, cancer-specific, and overall survival after curative …

SH Kim, B Park, EC Hwang, SH Hong… - Frontiers in …, 2019 - frontiersin.org
We evaluated prognostic risk factors of recurrence-free survival (RFS), metastasis-free
survival (MFS), cancer-specific survival (CSS), and overall survival (OS) outcomes in …

[PDF][PDF] 伴有静脉癌栓肾癌患者手术效果及其相关预后因素分析

刘志, 汪雄, 周佳维, 张斌, 陶陶, 肖峻 - 临床泌尿外科杂志, 2023 - lcmwen.whuhzzs.com
目的: 探讨伴有静脉癌栓肾癌患者行根治性肾切除联合静脉癌栓取出术的手术疗效及相关预后
因素. 方法: 回顾性分析2013 年5 月—2022 年2 月于中国科学技术大学附属第一医院(安徽省立 …

The evolving landscape of cytoreductive nephrectomy in metastatic renal cell carcinoma

H Studentova, M Spisarova, A Kopova, A Zemankova… - Cancers, 2023 - mdpi.com
Simple Summary For a significant period of time, the removal of the primary tumor termed
cytoreductive nephrectomy has been considered the standard of care in patients with …